“…In contrast to this study, the mean cases of the disease in the study of Shadmanfar et al 30 (12% remission, 8% weak, 62% moderate, and 18% high activity) and the study by Kavoodi et al (5.2% high, 50.4% moderate (28.1% low and in 16.3% remission) was more than our study. 20 Also, contrary to this study, in Abbasi et al, 29 the severity of the disease was reported to be low by 56.2%, 21.5% moderate, and high in 22.2%, the proportion of mild cases was higher. Severe cases of the disease in this study were higher than the Salesi et al 21 (Mean DAS28 score in the studied patients was 5.5 ± 1.2).…”